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Agreement between hospital and primary care on diagnostic
labeling for COPD and heart failure in Toronto, Canada: a
cross-sectional observational study
Michelle Greiver1,2,3,4, Frank Sullivan1,4,5,6, Sumeet Kalia1, Babak Aliarzadeh1, Deepak Sharma6, Steven Bernard6, Christopher Meaney1,
Rahim Moineddin1,4, David Eisen1,2,3, Navid Rahman6 and Tony D’Urzo1
Patients with chronic obstructive pulmonary disease (COPD) or heart failure (HF) are frequently cared for in hospital and in primary
care settings. We studied labeling agreement for COPD and HF for patients seen in both settings in Toronto, Canada. This was a
retrospective observational study using linked hospital-primary care electronic data from 70 family physicians. Patients were 20
years of age or more and had at least one visit in both settings between 1 January 2012 and 31 December 2014. We recorded
labeling concordance and associations with clinical factors. We used capture-recapture models to estimate the size of the
populations. COPD concordance was 34%; the odds ratios (ORs) of concordance increased with aging (OR 1.84 for age 75+ vs. <65,
95% CI 0.92–3.69) and more inpatient admissions (OR 2.89 for 3+ visits vs. 0 visits, 95% CI 1.59–5.26). HF concordance was 33%; the
ORs of concordance decreased with aging (OR 0.39 for 75+ vs. <65, 95% CI 0.18–0.86) and increased with more admissions (OR=
2.39; 95% CI 1.33–4.30 for 3+ visits vs. 0 visits). Based on capture-recapture models, 21–24% additional patients with COPD and
18–20% additional patients with HF did not have a label in either setting. The primary care prevalence was estimated as 748 COPD
patients and 834 HF patients per 100,000 enrolled adult patients. Agreement levels for COPD and HF were low and labeling was
incomplete. Further research is needed to improve labeling for these conditions.
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INTRODUCTION
A foundational activity for the assessment of quality of care is
correctly labeling patients that have a health condition of interest
so that patient cohorts can be generated.1 Quality of care can then
be measured, monitored, and improved for this cohort. Patients
with high-risk conditions such as heart failure (HF) or chronic
obstructive pulmonary disease (COPD) often receive care in both
primary care and hospital settings. Exacerbations of COPD and HF
are leading causes of hospital admissions in many parts of the
world2–4 and there is increasing focus on strategies to reverse
these trends. Upon discharge from hospital these patients are
often advised to follow-up with their primary care physician or
health care provider. Understanding how patient diagnoses are
documented in these different settings has important clinical and
research implications. For example, estimating levels of agreement
between diagnostic labeling in primary care practices and
hospitals that share the care of patients may facilitate patient
management and provide clarity on the state of research
preparedness of respective databases, including the size of the
populations of interest.
Presently, integrated care systems do not exist in Canada’s
largest province, Ontario. However, the province has geographi-
cally based referral patterns and informal physician networks.5
That is, primary care physicians have high “loyalty” and tend to
refer to local colleagues and local hospitals. This loyalty has
recently been estimated to be about 70%,5 suggesting that most
of the clinical data on both primary and inpatient care for majority
of patients exists in combined local systems.
In Toronto, Canada, the North York General Hospital (NYGH) and
its afﬁliated primary care physician community have recently co-
created a hospital primary care analytical database, the Health
Databank Collaborative (HDC).6 This database contains linked
clinical data from NYGH and data from the primary care Electronic
Medical Records (EMRs) of consenting family physicians, extracted
and managed through work done by the UTOPIAN Primary Care
Research Network, 1 of 11 networks participating in the Canadian
Primary Care Sentinel Surveillance Network, CPCSSN.7
Our objectives were to generate cohorts of patients seen in
both settings labeled as having HF or COPD, to estimate
agreement on recorded labels of COPD or HF, to determine
patient factors associated with agreement on labeling, and to
estimate the size of the populations of interest.
RESULTS
Seventy primary care physicians afﬁliated with NYGH contributed
EMR data to HDC during this study. There were 101,501 patients
age 20 or more as of 31 December 2014 enrolled with the
practices of these physicians. Patient characteristics are shown in
Tables 1a and 1b. The odds ratios and adjusted probabilities of
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having a concordant diagnostic label for COPD and HF are shown
in Tables 2 and 3, respectively.
COPD
Five hundred seventy-eight patients had charts labeled with a
diagnosis of COPD in at least one setting. 59% were women; the
mean age was 77.6 years and the mean number of co-morbidities
was 2.49. 36% of these patients were labeled as having COPD only
in primary care, 30% were labeled only in the hospital and 34%
were concordant (the two settings agreed on labeling). Of those
concordant, 128 (65%) were initially labeled as having a diagnosis
of COPD in primary care and 67 (35%) were initially labeled with
COPD in the hospital.
The odds ratios and adjusted probabilities of concordant
labeling were higher with increasing age (OR 1.84 for patients
age 75 years or more compared to <65, 95% CI 0.92–3.69), greater
number of co-morbidities (OR 4.6 for 3 or more co-morbidities
compared to 0 or 1, 95% CI 2.4–8.8), and higher number of
inpatient admissions (OR 2.9 for 3 or more inpatient admissions
compared to none, 95% CI 1.6–5.3). The most socioeconomically
deprived patients were more likely to have concordant labeling,
although this effect was not statistically signiﬁcant (OR 0.50 for
least deprived vs. most deprived, 95% CI 0.25–1.02). There were no
signiﬁcant differences by patient gender, number of emergency
department visits, or number of primary care encounters.
37% of patients with COPD were seen in the ED only (no
inpatient admissions). 21.9% of those had concordant labeling as
shown in Tables 1a and 1b. The adjusted probability of
Table 1a. Patient characteristics according to setting with chronic obstructive pulmonary disease labeling
Patients labeled only in primary
care
Patients labeled only in
hospital
Patients labeled in both
settings
Total
N Row percentage (%) N Row percentage (%) N Row percentage (%) N
Age range (years)
<65 52 62.7 17 20.5 14 16.9 83
65–74 38 40.9 28 30.1 27 29.0 93
75+ 122 30.3 126 31.3 154 38.3 402
Deceased
No 200 41.4 136 28.2 147 30.4 483
Yes 12 12.6 35 36.8 48 50.5 95
Gender
F 125 36.7 102 29.9 114 33.4 341
M 87 36.7 69 29.1 81 34.2 237
No. of co-morbidities
0–1 31 21.8 89 62.7 22 15.5 142
2 63 41.7 41 27.2 47 31.1 151
3+ 118 41.4 41 14.4 126 44.2 285
Income quintiles
1 (lowest income) 18 33.3 8 14.8 28 51.9 54
2 25 43.1 14 24.1 19 32.8 58
3 28 35.0 23 28.8 29 36.3 80
4 54 46.6 28 24.1 34 29.3 116
5 (highest income) 60 39.7 34 22.5 57 37.7 151
Missing 27 22.7 64 53.8 28 23.5 119
No. of visits to emergency departmenta
0 29 21.8 59 44.4 45 33.8 133
1 103 49.0 49 23.3 58 27.6 210
2 32 39.5 15 18.5 34 42.0 81
3+ 48 31.2 48 31.2 58 37.7 154
No. of encounters with primary care physiciana
1–2 5 21.7 11 47.8 7 30.4 23
3–9 24 27.3 35 39.8 29 33.0 88
10+ 183 39.2 125 26.8 159 34.0 467
No. of inpatient admissionsa
0 132 61.4 36 16.7 47 21.9 215
1 55 30.7 59 33.0 65 36.3 179
2 12 14.8 35 43.2 34 42.0 81
3+ 13 12.6 41 39.8 49 47.6 103
Total 212 36.7 171 29.6 195 33.7 578
aDuring the 3-year period of interest (1 January 2012 to 31 December 2014)
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concordance for patients with ED visits only was 25% (95% CI
16–37%) as shown in Table 2.
Heart failure
Six hundred ninty-one patients had charts labeled with a
diagnosis of HF in at least one setting. 62% were women; the
mean age was 83 years and the mean number of co-morbidities
was 2.0. 19% were labeled as having HF only in primary care, 48%
were labeled only in the hospital and 33% were concordant (the
two settings agreed on labeling). Of those concordant, 88 (39%)
were initially labeled as having a diagnosis of HF in primary care
and 137 (61%) were initially labeled in the hospital.
The odds ratios and adjusted probabilities of patients having a
label of HF in both settings decreased as age increased (OR 0.39
for patients age 75 years or more compared to <65, 95% CI
0.18–0.86). Patients that died during the period of observation
were more likely to have agreement on diagnostic labeling (OR=
1.99, 95% CI 1.29–3.08). An increasing number of co-morbidities
also increased the likelihood of concordance (OR= 2.04 for 3 or
more co-morbidities vs. none; 95% CI 1.26–3.09), as were more
inpatient visits (OR= 2.39; 95% CI 1.33–4.30 for 3+ visits vs. 0
visits). There were no signiﬁcant differences by patient gender,
income quintiles, number of emergency department visits, or
number of primary care encounters.
20% of patients with HF were seen in the ED only (no inpatient
admissions); 25.2% of those had concordant labeling as shown in
Tables 1a and 1b. The adjusted probability of concordance for
patients with ED visits only was 32% (95% CI 20–46%), as shown in
Table 2.
Table 1b. Patient characteristics according to setting with heart failure labeling
Patients labeled only in
primary care
Patients labeled only in
hospital
Patients labeled in both
settings
Total
N Percentage (%) N Percentage (%) N Percentage (%) N
Age range (years)
<65 8 21.1 13 34.2 17 44.7 38
65–74 21 28.4 25 33.8 28 37.8 74
75+ 104 18.0 295 50.9 180 31.1 579
Deceased
No 113 21.4 256 48.5 159 30.1 528
Yes 20 12.3 77 47.2 66 40.5 163
Gender
F 83 19.3 217 50.5 130 30.2 430
M 50 19.2 116 44.4 95 36.4 261
No. of co-morbidities
0–1 29 11.2 176 67.7 55 21.2 260
2 42 21.3 81 41.1 74 37.6 197
3+ 62 26.5 76 32.5 96 41.0 234
Income quintiles
1 (lowest income) 13 21.0 23 37.1 26 41.9 62
2 15 20.8 25 34.7 32 44.4 72
3 25 27.2 32 34.8 35 38.0 92
4 27 22.1 53 43.4 42 34.4 122
5 (highest income) 34 21.7 57 36.3 66 42.0 157
Missing 19 10.2 143 76.9 24 12.9 186
No. of visits to emergency departmenta
0 21 9.7 121 55.8 75 34.6 217
1 57 28.4 86 42.8 58 28.9 201
2 18 15.5 54 46.6 44 37.9 116
3+ 37 23.6 72 45.9 48 30.6 157
No. of encounters with primary care physiciana
1–2 1 1.9 41 75.9 12 22.2 54
10+ 118 22.7 221 42.5 181 34.8 520
3–9 14 12.0 71 60.7 32 27.4 117
No. of inpatient admissionsa
0 68 48.9 36 25.9 35 25.2 139
1 46 18.1 122 48.0 86 33.9 254
2 10 7.9 73 57.9 43 34.1 126
3+ 9 5.2 102 59.3 61 35.5 172
Total 133 19.2 333 48.2 225 32.6 691
aDuring the 3-year period of interest (1 January 2012 to 31 December 2014)
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Capture-recapture models
Using capture-recapture models, we determined that 21–24%
additional patients with COPD and 18–20% additional patients
with HF did not have the condition labeled in their chart in either
setting. The data are presented in Tables 4a and 4b and Fig. 1.
After adjustment for patient characteristics, the population size
was estimated to be 760 patients (95% CI 695–837) with COPD
and 847 patients (95% CI 787–918) with HF. Given that there were
101,501 patients enrolled to the primary care physicians in this
cohort, we expect to ﬁnd 748 COPD patients per 100,000 enrolled
adult patients and 834 HF patients per 100,000 enrolled adult
patients.
DISCUSSION
We found signiﬁcant disagreement between hospital and primary
care records on labeling for COPD and HF as the two settings
agreed on only a third of patients. About a ﬁfth of all patients had
no diagnostic labels in either setting. Agreement on a diagnostic
label was more likely when there were more inpatient admissions
but not when there were more primary care visits. The estimated
prevalence of COPD or HF associated with hospitalization in
primary care practices was slightly less than 1% for each condition.
There is scant information on labeling agreement between
hospital and primary care for chronic conditions with high impact
on health; one study in Spain found low concordance for a
number of conditions, including COPD and HF.8 A study in
Scotland found low levels of concordance for incident myocardial
infarcts, strokes, and ischemic heart disease.9 The lack of
agreement on diagnostic labels in our study is surprising, given
the fact that the two conditions we studied are associated with
signiﬁcant morbidity and mortality and are leading causes of
hospital admission and re-admissions.2–4
Misclassiﬁcations of COPD and HF (both under-diagnosis and
overdiagnosis) are common.10–12
Chart audits for the presence of appropriate testing and
diagnostic criteria would be needed in both settings to determine
diagnostic accuracy of in this study. This would include spirometry
for COPD13 and echocardiography and brain natriuretic peptide
for HF.12,14 We therefore make no inferences about the accuracy of
labeling. It would be reasonable to assume that there are errors in
both settings and this would at least partially explain the lack of
agreement.
The prevalence of COPD in Canada has been estimated at 4%
using self-reports, which underestimate COPD.15 Recent spirome-
try testing for a random sample of the population as part of the
Canadian Health Measures Survey found a prevalence of 17% for
COPD.16 The prevalence of moderate to severe COPD (GOLD III
and IV) was 1%.16 We report an estimated prevalence of 0.9% in
this population of patients with hospital admissions. We are not
able to determine from our study whether this difference is due to
under-diagnosis or to our population having more severe disease.
Under-diagnosis of COPD is a common ﬁnding in primary care,17,18
and this might in part be related to lack of access to spirometry in
primary care.19
It is relevant to note that even among patients admitted to
hospital with a diagnosis of COPD, less than 10% of such patients
undergo conﬁrmatory spirometry and about one-third do not
demonstrate spirometric features compatible with COPD.20 These
data highlight that factors affecting diagnostic labeling may
include availability of objective data to conﬁrm COPD diagnosis as
well as practices utilized in both the hospital and community clinic
settings which drive how data are entered into medical records.
The HF prevalence of 0.8% in our study is comparable to the
self-reported prevalence of HF in Canada of 1%.21 Yearly rates of
hospital admission for HF in Canada have been decreasing and
were 204 per 100,000 population in 2014.22 However, a recent
study found that 83.1% of patients followed with HF in the
community have had at least one hospitalization in a 5-year
period, with the majority of reasons (61.9%) being non-
cardiovascular.23
Table 2. Odds ratios of having concordant labeling (label present in both settings) for COPD and heart failure
COPD Heart failure
Effect Index group Reference group Odds ratio (95% conﬁdence interval) Odds ratio (95% conﬁdence interval)
Age range (years) 65–74 <65 1.37 (0.62–3.05) 0.47 (0.19–1.17)
75+ <65 1.84 (0.92–3.69) 0.39 (0.18–0.86)
Gender F M 0.92 (0.62–1.38) 0.72 (0.49–1.05)
Deceased Yes No 1.9 (1.12–3.23) 1.99 (1.29–3.08)
No. of co-morbidities 2 0–1 2.95 (1.49–5.83) 1.76 (1.08–2.88)
3+ 0–1 4.6 (2.41–8.76) 2.04 (1.26–3.29)
Income quintiles 2 1 0.35 (0.15–0.82) 1.33 (0.62–2.86)
3 1 0.51 (0.23–1.11) 1.07 (0.52–2.21)
4 1 0.35 (0.17–0.74) 0.73 (0.37–1.47)
5 1 0.5 (0.25–1.02) 1.13 (0.58–2.21)
No. of ED visitsa 1 0 1.05 (0.58–1.9) 0.68 (0.41–1.15)
2 0 1.48 (0.75–2.94) 1.13 (0.65–1.99)
3+ 0 1.12 (0.62–2.02) 0.69 (0.4–1.18)
No. of inpatient visitsa 1 0 1.91 (1.11–3.3) 1.95 (1.13–3.39)
2 0 2.47 (1.29–4.73) 2.05 (1.08–3.89)
3+ 0 2.89 (1.59–5.26) 2.39 (1.33–4.3)
No. of primary care visitsa 3 to 9 1 to 2 0.84 (0.26–2.67) 1.02 (0.42–2.47)
10+ 1 to 2 0.58 (0.19–1.72) 1.23 (0.54–2.8)
COPD chronic obstructive pulmonary disease, ED emergency department
Signiﬁcant results have been bolded
aDuring the 3-year period of interest (1 January 2012 to 31 December 2014)
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More patients were labeled with COPD only in the community
rather than only in the hospital. Many cases of COPD are mild
(GOLD I and II) and may not be perceived as impacting morbidity
in the hospital but could be labeled in the community due to case
ﬁnding for patients who smoke or have clinical features such as
chronic cough. The opposite was present for HF, with 48% of
patients labeled only in the hospital, even though they were seen
by their family physician after a hospitalization. Both COPD and HF
are Ambulatory Care Sensitive Conditions, meaning that optimal
care in the community can reduce hospitalizations and emergency
department visits.24 Appropriate diagnostic labeling of patient
charts is needed to monitor quality of care.1 Reasons for lack of
labeling in the community following hospitalization could include
poor communication between hospital and primary care25 or
disagreement about the diagnosis. Reducing this gap in con-
cordance is important it terms of promoting a robust primary care
data base for research.
Concordance for both conditions increased with an increasing
number of hospitalizations during the 3-year period, perhaps
reﬂecting more opportunities for reports mentioning the condi-
tions being forwarded from the hospital to primary care. Older age
was associated with greater concordance for COPD but the
opposite for HF; this unexpected ﬁnding should be conﬁrmed and
would beneﬁt from further study. Some factors that might have
inﬂuenced our ﬁndings include the fact that approximately half of
hospital re-admissions in patients with HF are related to co-
morbidities, polypharmacy, and other conditions associated with
HF.26
Our patients with HF were older than patients with COPD (77 vs.
83 years). Furthermore, we noted that there were more female
patients among our population of HF patients. Older HF patients
are more likely to be female.26 These patients also tend to have
higher rates of non-cardiovascular conditions,26 which may drive
patients to seek medical attention and inﬂuence diagnostic
labeling in both the primary and hospital settings.
It is important to mention that we did not evaluate
concordance among those patients with a diagnosis of both HF
and COPD. Among individuals with HF the prevalence of COPD
ranges between 20 and 32%, and reports suggest that 10% of
hospitalized HF patients also suffer from COPD.27 Conversely, HF is
prevalent in more than 20% of patients with COPD.28,29 It was
beyond the scope of this study to understand how concomitant
illness with COPD and HF might inﬂuence concordance rates in
the two settings we studied.
Understanding the concordance of this particularly high-risk
population between the two settings and conﬁrmation of
diagnosis by echocardiography and spirometry would be advan-
tageous in the overall care of such individuals.
Limitations
The study had several strengths. It reﬂected data from routine
clinical care for patients with COPD and HF in community-based
primary care and hospital care. Data were extracted from several
different EMR platforms, accounting for a variety of EMR-speciﬁc
data entry processes for diagnostic labeling by clinicians. Despite
these strengths, this study includes several shortcomings. This was
a convenience sample of primary care practices that contributed
EMR data to UTOPIAN, rather than a random sample. Correction of
an inaccurate diagnosis is another explanation for some of the
discrepancy. For example, a chesty smoker may be coded as
Table 3. Adjusted probabilities of having concordant labeling (label
present in both settings) for COPD and heart failure
COPD Heart failure
Effect Value Adjusted probability
(95% conﬁdence
interval)
Adjusted probability
(95% conﬁdence
interval)
Age range (years) <65 0.32 (0.18–0.5) 0.59 (0.39–0.76)
65–74 0.39 (0.25–0.55) 0.40 (0.26–0.56)
75+ 0.46 (0.35–0.57) 0.36 (0.27–0.45)
Gender F 0.38 (0.27–0.5) 0.41 (0.3–0.53)
M 0.40 (0.28–0.53) 0.49 (0.37–0.62)
Deceased Yes 0.47 (0.32–0.62) 0.53 (0.4–0.67)
No 0.31 (0.22–0.43) 0.37 (0.27–0.48)
No. of co-morbidities 0–1 0.21 (0.13–0.32) 0.35 (0.24–0.47)
2 0.44 (0.3–0.59) 0.48 (0.35–0.62)
3+ 0.55 (0.41–0.69) 0.52 (0.38–0.65)
Income quintiles 1 0.58 (0.4–0.74) 0.48 (0.31–0.65)
2 0.32 (0.19–0.5) 0.55 (0.39–0.7)
3 0.41 (0.26–0.57) 0.50 (0.34–0.65)
4 0.32 (0.2–0.47) 0.40 (0.27–0.55)
5 0.41 (0.28–0.55) 0.51 (0.38–0.65)
No. of ED visitsa 0 0.36 (0.24–0.5) 0.49 (0.36–0.61)
1 0.37 (0.24–0.51) 0.39 (0.27–0.53)
2 0.45 (0.29–0.62) 0.52 (0.37–0.67)
3+ 0.38 (0.26–0.52) 0.40 (0.26–0.55)
No. of inpatient
visitsa
0 0.25 (0.16–0.37) 0.32 (0.20–0.46)
1 0.39 (0.26–0.53) 0.47 (0.35–0.6)
2 0.45 (0.3–0.61) 0.49 (0.34–0.64)
3+ 0.49 (0.33–0.64) 0.53 (0.39–0.66)
No. of primary care
visitsa
1–2 0.45 (0.21–0.7) 0.43 (0.24–0.64)
3–9 0.40 (0.27–0.55) 0.43 (0.3–0.58)
10+ 0.32 (0.24–0.41) 0.48 (0.38–0.58)
COPD chronic obstructive pulmonary disease, ED emergency department
aDuring the 3-year period of interest (1 January 2012 to 31 December 2014)
Table 4a. Proportions of patients with a label of COPD captured in different settings, estimated additional proportion of missing patients and
estimated population size
Model Patients labeled
in hospital
Patients labeled in
primary care
Patients labeled
in both
Additional patients not
labeled in either setting
Estimated population size
(95% conﬁdence interval)
COPD= no covariate 30% 37% 34% 24% (19–30%) 764 (710–827)
COPD= age 30% 36% 34% 24% (19–30%) 763 (709–826)
COPD= age+ sex 32% 34% 34% 24% (18–30%) 763 (708–828)
COPD= age+ sex+ income
quintile
29% 34% 37% 21% (15–27%) 734 (681–796)
COPD= age+ sex+ income
quintile+ comorbidities
32% 34% 34% 24% (17–31%) 760 (695–837)
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“COPD” by a physician in the ED and subsequently corrected by
the family physician after spirometry. A breathless patient coded
by a family physician as HF may be corrected after testing during a
hospital admission. However, we note that in Canadian family
practices, adding a health condition to the summary health proﬁle
is not a trivial activity, as this is considered the “master list” for
signiﬁcant problems in the health record, and is recognized as
such by regulatory authorities.30
We only counted hospital admissions and ED visits; there are
several other reasons for a visit to the hospital, including
diagnostic imaging. We would not necessarily expect complete
labeling for major health conditions if the patient presented for
imaging only. It is reasonable, however, to expect major
conditions, such as COPD or HF, to be labeled in a patient’s chart
during a hospital admission.
Patients may present to ED with minor conditions; coding for
COPD or HF may not have been entered in those cases. We were
unable to exclude visits for minor conditions from the dataset and
provided results excluding patients seen only in ED. In a random
audit of 100 patients with COPD and HF for this study, only three
ED visits with COPD and two ED visits with HF were not followed
by an admission.
We did not collect several variables relevant to the diagnosis of
COPD or HF, as these were not available in the HDC database.
These variables include echocardiograms and spirometry results.
The data were from a single hospital, and do not reﬂect
information on patients admitted to other hospitals in the area.
However, regional loyalty in our setting is reasonably high at an
estimated 70%, reﬂecting the share of patients with COPD or HF
from primary care physicians seen at the hospital.5 We studied
labeling concordance, which would not be impacted by admission
elsewhere. All family physicians in this study were afﬁliated with
NYGH.
Conclusions
We found low rates of labeling agreement for COPD and HF
between a hospital and its primary care community as well as
missing labels in both settings. This points to opportunities to
improve the documentation of these high-risk, high-cost condi-
tions. Further research is needed to understand and explore
factors that inﬂuence diagnostic labeling and agreement. Identify-
ing strategies to improve diagnostic labeling between the hospital
and community clinics may also serve to develop robust data
bases which can be used to promote patient care and
collaborative research initiatives.
METHODS
Study design
This was a cross-sectional retrospective observational study using data
from the NYGH HDC database; we applied the STROBE checklist for
reporting observational studies.31
Data sources
EMR data routinely entered in primary care charts were used for this study.
These data were extracted and managed through work done by UTOPIAN,
the University of Toronto Practice-Based Research Network. UTOPIAN is
one of 12 networks participating in the Canadian Primary Care Sentinel
Surveillance Network, CPCSSN.7 CPCSSN is Canada’s largest primary care
EMR-based research and surveillance database; all contributing networks
Table 4b. Proportions of patients with a label of heart failure captured in different settings, estimated additional proportion of missing patients and
estimated population size
Model Patients labeled
in hospital
Patients labeled in
primary care
Patients labeled
in both
Additional patients not
labeled in either setting
Estimated population size
(95% conﬁdence interval)
HF= no covariate 46% 19% 35% 20% (14–26%) 859 (799–929)
HF= age 46% 19% 35% 20% (14– 26%) 860 (799–930)
HF= age+ sex 36% 25% 36% 20% (14–27%) 867 (800–946)
HF= age+ sex+ income
quintile
34% 26% 39% 19% (12–25%) 849 (787–923)
HF= age+ sex+ income
quintile+ comorbidities
34% 26% 39% 18% (12–25%) 847 (787–918)
COPD chronic obstructive pulmonary disease, HF heart failure
(a)  COPD (b) Heart failure 
Fig. 1 Venn diagrams for number of patients labeled for COPD and heart failure per site, using capture-recapture models: a COPD, One
hundred seventy-one patients were labeled only in the hospital, 212 were labeled only in primary care, and 195 in both. One hundred eighty-
two patients were not labeled in either setting. b Heart failure, Three hundred thirty-three patients were labeled only in the hospital, 133 were
labeled only in primary care, and 225 in both. One hundred ﬁfty-six patients were not labeled in either setting
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use similar data extraction and management processes and these have
been previously described.7 Brieﬂy, consenting family physicians and other
primary care providers contribute de-identiﬁed EMR data to the UTOPIAN
data repository; posters informing patients about the study are present in
the waiting rooms of participating practices, patients can opt-out if they
choose to do so.7,32
The primary care data were linked to the hospital’s database using an
encrypted identiﬁer for each patient.6 The linked data were analyzed.
Patient population
The population of interest consisted of patients age 20 or more as of 31
December 2014 or as of date deceased, seen at least once in both settings
(hospital and primary care) during a 3-year period (1 January 2012 to 31
December 2014). Patients were enrolled to a family physician contributing
data to the HDC. There must have been a diagnostic label of COPD or HF
recorded in at least one setting at any time prior to 31 December 2014.
There must have been at least one visit to the primary care physician
following the hospital visit where HF or COPD had initially been recorded,
or one Hospital visit where there was a pre-existing HF or COPD diagnosis
in the primary care record. The generation of the cohort for COPD is
described in Fig. 2. A similar process was used for HF.
For the hospital, standardized information on acute inpatient care and
emergency care is extracted from each chart and recorded using ICD10
codes in the Canadian Institute for Health Information Discharge Abstract
Database (CIHI DAD)33 and CIHI National Ambulatory Care Reporting
System (NACRS).34 Trained auditors abstract data from the chart, using a
standardized manual, and record ﬁndings as structured data. The CIHI
diagnostic types used were the Most Responsible Diagnosis and pre-admit
comorbidity.33
We used ICD-10-CA codes for HF consistent with those in CIHI DAD/
NACRS and recommended as indicating HF by the recent Health Quality
Ontario Quality-Based Procedures: I50.x, I25.5, I40.x, I41.x, I42.x, I43.x.35 For
COPD, we used ICD-10-CA J41-J44.36
For primary care, we used data present in the summative health proﬁle
of the chart. In Canada, provincial licensing organizations recommend
using the summative health proﬁle as a standard area for recording the
presence of important chronic conditions in primary care.30,37 We included
patients with a coded diagnosis for HF (ICD9 428) or COPD (ICD9 491, 492,
496) or free text indicating either condition. A similar approach was used to
validate the CPCSSN case deﬁnitions.38 Validation studies report good to
excellent sensitivity and speciﬁcity for ICD9 codes 491, 492, and 496 for
COPD39 and 498 for HF.40 CPCSSN has a coding tool that is applied when
free text for diagnosis is present in the health proﬁle and converts free text
to ICD9 codes; we used this coding tool. In summary, any entry containing
COPD, CHRONIC BRONCHITIS, EMPHYSEMA, CHRONIC AIRWAY OBSTRUC-
TION, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, and any other
keywords that indicate COPD were coded as COPD. HEART FAILURE,
HEARTFAILURE, HT FAILURE, BIVENTRICULAR FAILURE, CARDIAC FAILURE,
WEAK HEART, CHF, CONGESTIVE HEART DISEASE, VENTRICULAR FAILURE
were used for HF. The tool excludes data where keywords indicate
uncertainty about the diagnosis; these include “not”, “unlikely”, “unremark-
able”, “absence of”, “check” before diagnosis keyword, or “?” before or after
the diagnosis keyword.
The following data elements were extracted from the HDC database:
patient age as of 31 December 2014 or date deceased, patient gender,
presence of co-morbidities, socioeconomic quintiles, and health care
utilization (number of primary care visits, hospital utilization). Co-
morbidities were derived from eight CPCSSN validated disease case
deﬁnition algorithms: diabetes, hypertension, osteoarthritis, depression,
COPD, dementia, epilepsy, Parkinson’s disease.38 One of the conditions
classiﬁed was COPD, so seven co-morbidities were measured for patients
with COPD.
Hospital utilization was determined by the number of emergency
department visits and inpatient admissions. If there was an emergency
department visit followed by an inpatient admission, this was counted as
one hospital inpatient admission.
We used geographically derived information to calculate income level.41
The Postal Code Conversion File, available from Statistics Canada, was used
to link the six-character postal codes to the standard 2011 Census
dissemination areas. Dissemination areas are small, stable parts of
neighborhoods that include between 400 and 700 persons (http://
www12.statcan.gc.ca/census-recensement/2011/ref/dict/geo021-eng.cfm).
Subsequently, the Postal Code Conversion File was used to assign
neighborhood income.42
Statistical analysis
All statistical analyses were conducted using SAS software, version 9.4 (SAS
Institute). We recorded whether labeling for COPD and HF was present in
the hospital and primary care records. We examined the proportion of
patients with concordant diagnostic labeling (where a label for each
condition was present in both settings) and association between labeling
concordance and clinical factors using random effects logistic regression
model. We also used capture-recapture model to estimate the size of the
patient population with COPD or HF that had been looked after in both
hospital and primary care. Capture-recapture consists of taking a sample
from a population, tagging each item sampled and placing Manuscript, all
changes accepted them back. The population is then re-sampled and the
tagged items are counted. The proportion of items tagged in the new
sample reﬂects the proportion in the population and the size of the
population can then be estimated. More details on capture-recapture
model are provided in the Supplementary File.
This study was reviewed and appoved by the Research Ethics Board
(REB) at the NYGH. UTOPIAN has received REB approval from the University
of Toronto and from the NYGH for the collection of EMR data. All
participating primary care providers have provided written informed
consent for the collection and analysis of their EMR data.
Data availability
The data that support the ﬁndings of this study are available from the
NYGH’s Ofﬁce of Research and Innovations. Requests for data may be
made at http://www.nygh.on.ca/Default.aspx?cid=3157&lang=1. The data
are not publicly available as they may contain patient-related information
that could compromise patient privacy. Derived data supporting the
ﬁndings of this study are available from the corresponding author upon
request.
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